Preventable adverse drug events in a hospital Emergency Department;Evitabilidad de los acontecimientos adversos inducidos por medicamentos detectados en un Servicio de Urgencias

Revista Clinica Espanola

Volumn 199, Issue 12, 1999, Pages 796-805

  Otero Lopez M J ^a   Bajo Bajo, A ^a   Maderuelo Fernandez J A ^a   Dominguez Gil Hurle A ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Adverse drug events; Drug therapy adverse effects; Iatrogenic disease epidemiology; Incidence; Medication errors; Preventability

Indexed keywords

ANTICOAGULANT AGENT; DIGOXIN; DIURETIC AGENT; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG MONITORING; EMERGENCY WARD; FEMALE; HUMAN; IATROGENIC DISEASE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; SELF MEDICATION; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; DRUG TOXICITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED;

EID: 0033394201     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Mundet X, Ibáñez L, Díez J, Bundó M, Fandos JM, Ferrán M. Reacciones adversas a medicamentos en un servicio de urgencias. Aten Primaria 1988; 5:263-268.
2. De Abajo FJ, Frías J, Lopo CR, et al. Las reacciones adversas a medicamentos como un motivo de consulta al servicio de urgencias de un hospital general. Med Clín (Barc) 1989; 92:530-535.
3. San Miguel MT, Vila MN, Azorín MD, et al. Atenciones en puerta de urgencias por reacciones adversas a medicamentos. Farm Clin 1992; 9:672-677.
4. Stoukides CA, D'Agostino PR, Kaufman MB. Adverse drug reaction surveillance in an emergency room. Am J Hosp Pharm 1993; 50:712-714.
5. Dennehy CE, Kishi DT, Louie C. Drug-related illness in Emergency Department patients. Am J Health-Syst Pharm 1996; 53:1.422-1.426.
6. Schneitman-McIntire O, Farnen TA, Gordon N, Chan J, Toy WA. Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Health-Syst Pharm 1996; 53:1.416-1.422.
7. Muñoz MJ, Ayani I, Rodrĩguez-Sasiain JM, Gutiérrez G, Aguirre C. Monitorización en un Servicio de Urgencias de reacciones adversas causadas por medicamentos en niños y adultos. Med Clín (Barc) 1998; 111:92-98.
8. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27:832-839.
9. Muehlberger N, Scheneeweiss S, Hasford J. Adverse drug reaction monitoring-cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Safety 1997: 6(suppl 3):71-77.
10. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279:1.200-1.205.
11. Pearson TF, Pittman DG, Longley JM, Grapes T, Vigliotti DJ, Mullis SR. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51:2.268-2.272.
12. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 1995; 274:29-34.
13. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16:701-707.
14. Goettler M, Schneewiss S, Hasford J. Adverse drug reactions monitoring-cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Safety 1997; 6 (suppl 3):79-90.
15. Seeger JD, Kong SX, Schumock GT. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients. Pharmacotherapy 1998; 18:1.284-1.289.
16. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995; 10:199-205.
17. American Society of Health-System Pharmacists. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am J Health-Syst Pharm 1998; 55:165-166.
18. Organización Mundial de la Salud. Vigilancia farmacológica internacional. Función del hospital. Serie de Informes Técnicos, 425. Ginebra, 1969.
19. Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA 1975; 234:1.236-1.241.
20. Ibáñez L, Laporte JR, Carné X. Adverse drug reactions leading to hospital admission. Drug Safety 1991; 6:450-459.
21. Anónimo. Centros Autónomos de Farmacovigilancia. Manual de Codificación Madrid: Ministerio de Sanidad y Consumo, 1994.
22. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27:538.
23. Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. En: Davis DM, ed. Textbook of adverse drug reactions (4th ed). Oxford: Oxford University Press, 1991; 18-45.
24. WHO. Collaborating Centre for International Drug Monitoring. Internatonal monitoring of adverse drug reactions. Ginebra, 1988.
25. Consejo General de Colegios Oficiales de Farmacéuticos. Catálogo de Especialidades Farmacéuticas. Madrid, 1995.
26. Williams RL. FDA position on product selection for ««narrow therapeutic index» drugs. Am J Health Syst Pharm 1997; 54:1.630-1.632.
27. Otero MJ, Bajo A, García Gutiérrez JF, Dominguez-Gil A. ¿Prevenible o inevitable?: una nueva etapa en el tema de la seguridad de los medicamentos. Med Clín (Barc) 1999; 112:398-399.
28. American Society of Health-System Pharmacists. ASHP strategic-planning report for 1998-9. Am J Health-Syst Pharm 1998; 55:1.717-1.721.
29. Leape LL, Bates DW, Cullen DJ, et al. System analysis of adverse drug events. JAMA 1995; 274:35-43.
30. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997; 277:312-317.
31. Leape LL. Error in medicine. JAMA 1994; 272:1.851-1.857
32. Del Rio MC, Prada C, Álvarez J. The use of medication by the Spanish population. Pharmacoepidemiol Drug Safety 1997; 6:41-48.
33. Hoigné R, Lawson DH, Weber E. Risk factors for adverse drug reactions epidemioloqical approaches. Eur J Clin Pharmacol 1990; 39:321-325.
34. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991; 114:956-966.
35. González Núñez J, Ripoll Lozano MA, Prieto Prieto J. Automedicación con antibióticos. Med Clin (Barc) 1998; 111:182-185.
36. Bigby J, Dunn J, Goldman L, et al. Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility. Am J Med 1987; 83:1.031-1.036.
37. Hallas J, Gram LF, Grodum E, et al. Drug related admission to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33:61-68.
38. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-384.
39. Alonso Roca R, Barroso Muñoz C, Álvarez Solanes I, Puche López N, Alcaraz Bethencourt. Anticoagulación oral en Atención Primaria. Inf Ter Sist Nac Salud 1997; 21:89-96.
40. Ansell JE, Buttaro ML, Voltis Thomas O, Knowlton CH, and the Anticoagulation Guidelines Task Force. Consensus Guidelines for coordinated outpatient oral anticoagulation therapy management. Ann Pharmacother 1997; 31:604-615.
41. Laporte JR. Automedicatión: ¿la información de los usuarios aumenta al mismo tiempo que el consumo? Med Clín (Barc) 1997; 109: 795-796.
42. The Challenge end Potential for Assuring Quality Health Care for the 21st Century. Pub. No. OM 98-0009. Department of Health and Human Services for the Domestic Policy Council, Washington, DC, June 17, 1998. Available from: http://www.ahcpr.gov/qual/21stcena.htm